GO:0048821 erythrocyte development: Host-Pathogen Interface, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048821 erythrocyte development describes the progression of an erythrocyte from formation to mature structure, and is a biological process term in the Gene Ontology.
• Erythrocyte development is not only a developmental process but also a critical host-pathogen interface, as mature red blood cells support the intraerythrocytic development of Plasmodium falciparum.
• The erythrocyte plasma membrane and its transporters, such as PMCA4b, regulate oxidative stress responses and influence malaria protection and artemisinin resistance.
• Sphingosine kinase and sphingosine-1-phosphate (S1P) signaling in erythrocytes are essential for vascular development and homeostasis, and become critical after plasma S1P depletion in anaphylactic shock.
• Bacterial pathogens such as Bartonella species interact with mammalian erythrocytes through specific molecular mechanisms, highlighting the erythrocyte surface as a target for host-pathogen studies.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal interrogation of genes involved in erythrocyte development and related host-pathogen interactions.
Description
Erythrocyte development, formally annotated as GO:0048821, is the biological process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure. This term captures the full developmental trajectory of red blood cells, including the stages that lead to a mature, functional erythrocyte capable of gas transport and immune modulation. Understanding this process is fundamental for researchers in hematology, developmental biology, and infectious disease, because erythrocytes are not merely passive oxygen carriers but active participants in host-pathogen interactions. The mature erythrocyte is the site of intraerythrocytic development for Plasmodium falciparum, the deadliest malaria parasite, making erythrocyte development a central axis in malaria research. Moreover, erythrocyte membrane proteins and signaling lipids influence oxidative stress responses and drug resistance, as shown for PMCA4b in malaria protection and artemisinin resistance. Sphingosine kinase and sphingosine-1-phosphate (S1P) produced by erythrocytes are also critical for vascular development and homeostasis, and their depletion can be lethal in anaphylactic shock. Thus, GO:0048821 is a nexus for understanding red blood cell biology, host-pathogen dynamics, and therapeutic targeting. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of erythrocyte development, its molecular players, disease relevance, and modern CRISPR-based methods for functional interrogation.
erythrocyte development At A Glance
| GO ID | GO:0048821 |
|---|---|
| GO term | erythrocyte development |
| Ontology | biological_process |
| Synonym | RBC development; red blood cell development |
| Definition | The process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure. |
| Major function | Production of mature erythrocytes capable of oxygen transport and participation in host-pathogen interactions. |
| Related disease areas | Malaria, anaphylactic shock, vascular homeostasis, bacterial infections. |
| Key molecular players | Sphingosine kinase, S1P, PMCA4b, Bartonella adhesins, Plasmodium proteins. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, imaging. |
What Is GO:0048821?
GO:0048821 erythrocyte development is defined as the process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure. In other words, it encompasses all cellular and molecular events that convert a developing erythroid cell into a mature red blood cell, including the acquisition of the characteristic biconcave shape, loss of organelles, and expression of hemoglobin and membrane proteins. This term is a biological process in the Gene Ontology and is synonymous with RBC development and red blood cell development.
Why Is erythrocyte development Important in Cell Biology?
Erythrocyte development is critically important because mature red blood cells are essential for oxygen delivery, but they also serve as hosts for pathogens and as regulators of vascular tone and immune responses. The intraerythrocytic development of Plasmodium falciparum depends on the erythrocyte environment, and understanding this process can inform malaria vaccine and drug development. Erythrocyte membrane proteins such as PMCA4b modulate oxidative stress and drug resistance, linking erythrocyte biology to antimalarial treatment outcomes. Sphingosine kinase and S1P from erythrocytes are redundant for vascular development under normal conditions but become essential after plasma S1P depletion, as seen in anaphylactic shock. Bacterial pathogens like Bartonella interact specifically with erythrocytes, and these interactions are important for understanding chronic bacteremia and endocarditis. Therefore, research on GO:0048821 has broad implications for hematology, infectious disease, immunology, and vascular biology.
• Erythrocyte development is the foundation for oxygen transport and carbon dioxide removal in all vertebrates.
• Mature erythrocytes are the obligate host cells for the intraerythrocytic stage of Plasmodium falciparum, making this process central to malaria pathogenesis.
• Erythrocyte membrane transporters such as PMCA4b influence oxidative stress and artemisinin resistance, with direct clinical implications for malaria treatment.
• Sphingosine kinase and S1P produced by erythrocytes are critical for vascular development and homeostasis, and their loss can cause fatal anaphylactic shock.
• Bacterial pathogens like Bartonella species exploit erythrocyte surface molecules for adhesion and invasion, linking erythrocyte development to zoonotic infections.
• Understanding erythrocyte development can reveal new targets for antimalarial drugs and vaccines, as pre-erythrocytic and blood-stage vaccines are actively developed.
• Erythrocyte development is a model system for studying cell differentiation, enucleation, and membrane remodeling.
• Genetic disorders of erythrocyte development, such as anemias and membranopathies, can be modeled using CRISPR-based approaches.
• Erythrocyte-derived S1P is a key regulator of lymphocyte trafficking and vascular barrier function.
• Studying erythrocyte development aids in the development of in vitro blood substitutes and transfusion medicine.
What Happens During erythrocyte development?
Erythropoiesis and terminal differentiation
In simple terms: This is the process where stem cells in the bone marrow become specialized red blood cells.
Erythrocyte development begins with the differentiation of hematopoietic stem cells into erythroid progenitors, followed by terminal differentiation into proerythroblasts, basophilic, polychromatophilic, and orthochromatic erythroblasts. These stages involve progressive hemoglobin accumulation, nuclear condensation, and organelle loss. The process is tightly regulated by erythropoietin and transcription factors. While the QuickGO definition focuses on the progression to mature structure, experimental studies often use erythroid cell lines and primary cells to dissect these steps. The mature erythrocyte is then released into circulation, where it can interact with pathogens such as Plasmodium falciparum, which requires the erythrocyte for its intraerythrocytic development.
Membrane remodeling and enucleation
In simple terms: The cell removes its nucleus and reshapes its membrane to become a flexible disc.
During terminal erythroid differentiation, the nucleus is expelled in a process called enucleation, and the plasma membrane undergoes extensive remodeling to generate the biconcave shape. This involves the reorganization of membrane skeleton proteins including spectrin, ankyrin, and band 3. The mature erythrocyte membrane contains transporters and channels that regulate ion homeostasis and oxidative stress. For example, the plasma membrane calcium ATPase PMCA4b (ATP2B4) plays a role in oxidative stress-mediated malaria protection and artemisinin resistance, highlighting the functional importance of membrane remodeling. Disruption of these processes can lead to hemolytic anemias and altered susceptibility to infections.
Sphingolipid metabolism and S1P signaling
In simple terms: Red blood cells produce a lipid signal that controls blood vessel development and immune cell movement.
Erythrocytes are a major source of sphingosine-1-phosphate (S1P), generated by sphingosine kinase (SPHK1/2). S1P is a bioactive lipid that regulates vascular development, lymphocyte egress, and endothelial barrier function. Studies using knockout mice have shown that platelet and erythrocyte sources of S1P are redundant for vascular development and homeostasis under normal conditions, but both become essential after plasma S1P depletion in anaphylactic shock. In the context of malaria, erythrocyte sphingosine kinase regulates the intraerythrocytic development of Plasmodium falciparum, and pharmacological modulation of sphingolipid metabolism can inhibit parasite development. Thus, sphingolipid metabolism is an integral part of erythrocyte development and function.
Host-pathogen interactions during erythrocyte development
In simple terms: Pathogens like malaria parasites and bacteria use red blood cells to grow and survive.
Mature erythrocytes are targets for several pathogens. Plasmodium falciparum invades erythrocytes and undergoes intraerythrocytic development, a process that depends on erythrocyte factors such as sphingosine kinase. The parasite also expresses transcriptional factors like PfAP2-06B that regulate erythrocyte invasion. Bacterial pathogens such as Bartonella species interact with mammalian erythrocytes through specific adhesins and invasins, leading to chronic bacteremia. These interactions highlight the importance of erythrocyte surface molecules and signaling pathways in host-pathogen dynamics. Understanding these mechanisms can inform the development of vaccines and therapeutics targeting erythrocyte-stage pathogens.
Regulation of erythrocyte development by oxidative stress and metabolic cues
In simple terms: Red blood cells must manage oxidative stress to survive and function properly.
Erythrocytes are constantly exposed to oxidative stress due to their high oxygen content. The plasma membrane calcium ATPase PMCA4b (ATP2B4) has been implicated in oxidative stress-mediated malaria protection and artemisinin resistance, suggesting that calcium signaling and oxidative stress responses are critical for erythrocyte function and survival. Additionally, sphingolipid metabolism and glucose uptake can be modulated by drugs such as amitriptyline, which inhibits Plasmodium development in infected red blood cells. These findings indicate that erythrocyte development and function are regulated by a complex interplay of metabolic, oxidative, and signaling pathways.
Key Genes Involved in GO:0048821 erythrocyte development
The following genes and proteins are key players in erythrocyte development, host-pathogen interactions, and related signaling pathways, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPHK1 | Sphingosine kinase 1; produces S1P | Regulates intraerythrocytic Plasmodium development; S1P signaling in vascular homeostasis |
| SPHK2 | Sphingosine kinase 2; produces S1P | Redundant with SPHK1 for vascular development; essential after S1P depletion |
| ATP2B4 | Plasma membrane calcium ATPase PMCA4b | Oxidative stress-mediated malaria protection and artemisinin resistance |
| PFAP2-06B | Plasmodium ApiAP2 transcription factor | Regulates erythrocyte invasion indirectly in P. falciparum |
| BARTONELLA_ADHESINS | Bartonella adhesins for erythrocyte binding | Mediate bacterial interaction with erythrocytes |
| S1PR1 | S1P receptor 1 | Mediates S1P signaling in vascular and immune cells |
| SLC4A1 | Band 3 anion exchanger | Major erythrocyte membrane protein; involved in membrane stability and CO2 transport |
| SPTA1 | Spectrin alpha chain | Cytoskeletal protein essential for erythrocyte membrane integrity |
| SPTB | Spectrin beta chain | Cytoskeletal protein essential for erythrocyte membrane integrity |
| ANK1 | Ankyrin 1 | Links spectrin to band 3; critical for membrane stability |
| EPOR | Erythropoietin receptor | Mediates erythropoietin signaling during erythroid differentiation |
| GATA1 | Transcription factor GATA1 | Master regulator of erythroid differentiation |
| KLF1 | Kruppel-like factor 1 | Regulates erythroid gene expression and hemoglobin switching |
| HBB | Hemoglobin beta chain | Oxygen transport; mutations cause sickle cell disease and thalassemia |
| HBA1 | Hemoglobin alpha 1 | Oxygen transport; mutations cause alpha-thalassemia |
| ALAS2 | Delta-aminolevulinate synthase 2 | Rate-limiting enzyme in heme biosynthesis |
| SLC7A11 | Cystine/glutamate transporter | Regulates redox balance in erythroid cells |
| PFEMP1 | Plasmodium falciparum erythrocyte membrane protein 1 | Mediates cytoadherence and immune evasion in malaria |
How Is erythrocyte development Regulated?
Erythrocyte development is regulated by a complex network of transcription factors, signaling pathways, and metabolic cues. Erythropoietin (EPO) signaling through its receptor (EPOR) is the primary driver of erythroid proliferation and survival. Downstream transcription factors such as GATA1 and KLF1 coordinate the expression of erythroid-specific genes, including hemoglobin and membrane proteins. Sphingosine-1-phosphate (S1P) signaling, produced by sphingosine kinases in erythrocytes, regulates vascular development and homeostasis, and its loss can be compensated by platelet-derived S1P under normal conditions but not after plasma S1P depletion. Oxidative stress pathways, including those involving PMCA4b (ATP2B4), modulate erythrocyte survival and susceptibility to malaria and artemisinin resistance. Additionally, metabolic regulators such as glucose uptake and sphingolipid metabolism can be targeted pharmacologically, as shown by amitriptyline inhibition of Plasmodium development in infected red blood cells. These regulatory mechanisms are critical for maintaining erythrocyte homeostasis and responding to environmental stressors.
erythrocyte development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPHK1 | Malaria; S1P signaling in vascular homeostasis | Knockout mice; erythrocyte-specific deletion |
| ATP2B4 | Malaria protection; artemisinin resistance | Point mutation knock-in; overexpression |
| PFAP2-06B | Plasmodium erythrocyte invasion | Parasite knockout; conditional knockdown |
| BARTONELLA_ADHESINS | Bartonella infection; chronic bacteremia | Bacterial knockout; erythrocyte binding assays |
| S1PR1 | Vascular development; anaphylactic shock | Knockout mice; conditional deletion |
Malaria and erythrocyte-pathogen interactions
Malaria, caused by Plasmodium falciparum, is a major global health burden. The parasite's intraerythrocytic development depends on the erythrocyte environment, including sphingosine kinase activity. Erythrocyte membrane proteins such as PMCA4b influence oxidative stress and artemisinin resistance, which can affect treatment outcomes. The parasite also regulates erythrocyte invasion through transcriptional factors like PfAP2-06B. Understanding these interactions is essential for developing new antimalarial drugs and vaccines, including pre-erythrocytic stage vaccines.
Bacterial infections and erythrocyte adhesion
Bartonella species, the causative agents of cat-scratch disease and bacillary angiomatosis, interact with mammalian erythrocytes through specific molecular mechanisms. These interactions facilitate bacterial persistence and dissemination, leading to chronic bacteremia and endocarditis. Studying erythrocyte development and surface molecules can reveal targets for preventing or treating Bartonella infections.
Vascular homeostasis and anaphylactic shock
Erythrocytes are a major source of sphingosine-1-phosphate (S1P), which regulates vascular development and homeostasis. While platelet and erythrocyte sources of S1P are redundant under normal conditions, both become essential after plasma S1P depletion in anaphylactic shock, a severe allergic reaction. This highlights the critical role of erythrocyte-derived S1P in vascular barrier function and immune cell trafficking.
Erythrocyte disorders and therapeutic targeting
Disorders of erythrocyte development, such as anemias and membranopathies, can result from mutations in genes like SPTA1, SPTB, ANK1, and SLC4A1. These conditions impair red blood cell stability and function. CRISPR-based models can be used to study these mutations and test therapeutic strategies. Additionally, pharmacological modulation of sphingolipid metabolism and glucose uptake, as shown with amitriptyline, can inhibit pathogen development in erythrocytes, suggesting potential for host-directed therapies.
From erythrocyte development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SPHK1 in erythrocytes regulate Plasmodium development? | Erythrocyte-specific SPHK1 knockout mice |
| Does ATP2B4 point mutation affect oxidative stress and artemisinin resistance? | CRISPR point mutation knock-in in erythroid cell lines |
| What is the role of PfAP2-06B in erythrocyte invasion? | Parasite gene knockout or knockdown |
| How do Bartonella adhesins mediate erythrocyte binding? | Bacterial knockout and erythrocyte binding assays |
| Is erythrocyte-derived S1P essential for vascular homeostasis? | Inducible erythrocyte-specific SPHK1/2 double knockout |
| Can overexpression of S1P receptors rescue S1P depletion? | Transgenic overexpression in mice |
How to Study the erythrocyte development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and loss-of-function phenotypes | Identify regulators of erythrocyte development and pathogen invasion |
| Point mutation knock-in | Effect of specific genetic variants | Model human polymorphisms in ATP2B4 and other genes |
| RNA-seq | Transcriptional changes | Profile erythroid differentiation and host response to infection |
| Proteomics | Protein abundance and modifications | Identify membrane proteins and signaling changes |
| Flow cytometry | Cell surface markers and parasite load | Quantify erythroid differentiation and Plasmodium infection |
| Live-cell imaging | Dynamic processes like enucleation and invasion | Visualize erythrocyte development and pathogen entry |
| Oxidative stress assays | ROS levels and antioxidant capacity | Assess PMCA4b function and artemisinin resistance |
| Erythrocyte binding assays | Pathogen adhesion to erythrocytes | Study Bartonella and Plasmodium interactions |
CRISPR-Cas9 knockout screening
CRISPR-Cas9 knockout screens are powerful for identifying genes essential for erythrocyte development and host-pathogen interactions. For example, genome-wide knockout screens in erythroid cell lines can reveal regulators of enucleation, hemoglobinization, and membrane stability. In the context of malaria, knockout of host genes such as SPHK1 can be used to assess their role in Plasmodium intraerythrocytic development. Similarly, knockout of parasite genes like PFAP2-06B can elucidate their function in erythrocyte invasion.
Point mutation and knock-in models
Point mutations in erythrocyte genes can be introduced using CRISPR-Cas9 homology-directed repair to model human genetic variants. For instance, mutations in ATP2B4 (PMCA4b) have been associated with oxidative stress-mediated malaria protection and artemisinin resistance, and knock-in models can validate these findings. Knock-in of fluorescent tags or epitope tags allows visualization and biochemical analysis of endogenous proteins in erythroid cells.
Transcriptomics and proteomics
RNA sequencing (RNA-seq) and mass spectrometry-based proteomics can profile gene expression and protein abundance during erythroid differentiation. These methods can identify novel regulators and pathways. For example, transcriptomic analysis of Plasmodium-infected erythrocytes can reveal parasite-induced changes in host gene expression. Proteomic studies of erythrocyte membranes can identify surface proteins involved in Bartonella adhesion.
Imaging and functional assays
Advanced imaging techniques, such as live-cell microscopy and flow cytometry, are used to study erythrocyte development, enucleation, and pathogen invasion. Flow cytometry can quantify erythroid differentiation markers and parasite load. Functional assays, such as erythrocyte binding assays and oxidative stress measurements, can assess the impact of genetic perturbations on erythrocyte function and host-pathogen interactions.
How CRISPR Can Be Used to Study GO:0048821 erythrocyte development
Knockout
CRISPR knockout is used to completely ablate genes involved in erythrocyte development to assess their function. For example, knocking out SPHK1 in erythroid cells can reveal its role in S1P production and Plasmodium development. Knockout of parasite genes like PFAP2-06B can determine their necessity for erythrocyte invasion. Knockout models are also valuable for studying erythrocyte membrane proteins and their contribution to stability and function.
Point Mutation
Point mutations can be introduced via CRISPR-Cas9 homology-directed repair to model human genetic variants. For instance, mutations in ATP2B4 (PMCA4b) associated with malaria protection and artemisinin resistance can be knocked into erythroid cell lines to study their effects on oxidative stress and drug response. Point mutation models are essential for understanding how specific amino acid changes affect protein function and disease susceptibility.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins or epitope tags, allows real-time tracking and biochemical analysis of endogenous proteins. For example, knocking in a GFP tag into the endogenous SPHK1 locus can enable visualization of its localization during erythrocyte development. Knock-in of human disease alleles into mouse models can also create more accurate models of erythrocyte disorders.
Overexpression
Overexpression of genes of interest can be achieved by CRISPR activation (CRISPRa) or by knock-in of a strong promoter. Overexpressing S1P receptors or sphingosine kinases can test whether increased signaling rescues phenotypes associated with S1P depletion. Overexpression models are useful for gain-of-function studies and for testing therapeutic hypotheses.
How EDITGENE Supports erythrocyte development Research
Researchers studying erythrocyte development-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models provide the most direct way to test this. Whether the goal is to validate a gene identified in a screen, model a human mutation, or overexpress a protective factor, EDITGENE offers a comprehensive suite of services to accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for erythrocyte development research.
Frequently Asked Questions About erythrocyte development
What is GO:0048821 erythrocyte development?
GO:0048821 is a Gene Ontology biological process term defined as the process whose specific outcome is the progression of an erythrocyte over time, from its formation to the mature structure. It is synonymous with RBC development and red blood cell development.
What genes are involved in erythrocyte development?
Key genes include SPHK1, SPHK2, ATP2B4 (PMCA4b), SLC4A1, SPTA1, SPTB, ANK1, EPOR, GATA1, KLF1, HBB, HBA1, and ALAS2. Pathogen genes such as PFAP2-06B also influence erythrocyte invasion.
How is erythrocyte development studied?
It is studied using CRISPR knockout, point mutation, knock-in, overexpression models, RNA-seq, proteomics, flow cytometry, imaging, and functional assays such as erythrocyte binding and oxidative stress measurements.
Why is erythrocyte development important for malaria research?
Mature erythrocytes host the intraerythrocytic development of Plasmodium falciparum, and erythrocyte factors like sphingosine kinase and PMCA4b influence parasite growth and drug resistance.
What is the role of sphingosine kinase in erythrocyte development?
Sphingosine kinase produces sphingosine-1-phosphate (S1P), which regulates vascular development and homeostasis. Erythrocyte sphingosine kinase also regulates intraerythrocytic Plasmodium development.
How does PMCA4b affect erythrocyte function?
PMCA4b (ATP2B4) is a plasma membrane calcium ATPase that modulates oxidative stress responses and has been linked to malaria protection and artemisinin resistance.
What diseases are associated with erythrocyte development?
Malaria, Bartonella infections, anaphylactic shock, hemolytic anemias, and vascular disorders are associated with erythrocyte development and function.
Can CRISPR be used to study erythrocyte development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study gene function in erythrocyte development and host-pathogen interactions.
What is the difference between erythrocyte development and erythropoiesis?
Erythropoiesis is the broader process of red blood cell production, while erythrocyte development (GO:0048821) specifically refers to the progression of an erythrocyte from its formation to the mature structure.
How does S1P signaling relate to erythrocyte development?
Erythrocytes are a major source of S1P, which regulates vascular development and immune cell trafficking. Platelet and erythrocyte S1P sources are redundant under normal conditions but essential after plasma S1P depletion.
Conclusion
GO:0048821 erythrocyte development is a fundamental biological process that encompasses the formation and maturation of red blood cells. Beyond its role in oxygen transport, erythrocyte development is central to host-pathogen interactions, vascular homeostasis, and disease pathogenesis. Key genes such as SPHK1, ATP2B4, and PFAP2-06B have been implicated in malaria, bacterial infections, and anaphylactic shock, highlighting the broad relevance of this process. Advances in CRISPR-based models, transcriptomics, and proteomics are accelerating our understanding of erythrocyte development and opening new avenues for therapeutic intervention. Researchers can leverage these tools to dissect the molecular mechanisms of erythrocyte development and translate findings into clinical applications.
References
- 1. Sah RK et al.. 2021. Erythrocyte sphingosine kinase regulates intraerythrocytic development of Plasmodium falciparum.. Sci Rep 11(1):1257 PMID: 33441957
- 2. Molina-Franky J et al.. 2020. Plasmodium falciparum pre-erythrocytic stage vaccine development.. Malar J 19(1):56 PMID: 32013956
- 3. Bojang KA. 2006. RTS,S/AS02A for malaria.. Expert Rev Vaccines 5(5):611-5 PMID: 17181435
- 4. Agrohi P et al.. 2026. Decoding the multifaceted role of erythrocyte PMCA4b in oxidative stress-mediated malaria protection and artemisinin resistance.. mBio 17(1):e0173825 PMID: 41400477
- 5. Shi Q et al.. 2025. An ApiAP2 Family Transcriptional Factor PfAP2-06B Regulates Erythrocyte Invasion Indirectly in Plasmodium falciparum.. Pathogens 14(11) PMID: 41305314
- 6. Deng H et al.. 2018. Molecular Mechanisms of Bartonella and Mammalian Erythrocyte Interactions: A Review.. Front Cell Infect Microbiol 8:431 PMID: 30619777
- 7. Gazit SL et al.. 2016. Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.. Circ Res 119(8):e110-26 PMID: 27582371
- 8. Hose M et al.. 2025. Amitriptyline inhibits Plasmodium development in infected red blood cells by modulating sphingolipid metabolism and glucose uptake.. Biomed Pharmacother 189:118331 PMID: 40633203
